FDA announces FY 2022 GDUFA science and research priorities
Regulatory NewsJoanne S. EglovitchAPIsBiologics/ biosimilars/ vaccinesCombination products/companion diagnosticsNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development